Heart Failure, Systolic: Clinical Trials

222 trials for Heart Failure, Systolic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

95 completed, 45 unknown, 25 recruiting, 18 terminated. 97 Not applicable, 29 Phase 4, 23 Phase 2, 14 Phase 3, 11 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable97Completed 40, Unknown 18, Recruiting 13, Terminated 10, Not yet recruiting 8, Withdrawn 6, Active not recruiting 1, Enrolling by invitation 1
Phase 429Completed 13, Unknown 10, Enrolling by invitation 3, Recruiting 1, Terminated 1, Withdrawn 1
Phase 223Completed 12, Withdrawn 3, Active not recruiting 2, Terminated 2, Unknown 2, Not yet recruiting 1, Recruiting 1
Phase 314Completed 7, Terminated 3, Not yet recruiting 2, Recruiting 1, Unknown 1
Phase 111Completed 7, Recruiting 2, Active not recruiting 1, Unknown 1
Early Phase 12Active not recruiting 1, Recruiting 1

Follow Heart Failure, Systolic: new trials by email Literature Review of Heart Failure, Systolic trials Research Report on Heart Failure, Systolic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacist-Assisted Titration of Rx to Implement Optimal Medical Therapy for Heart Failure
Pharmacist/Cardiologist Virtual Team Digital Consultation - Heart Failure, Heart Failure, Systolic
Not applicableNot yet recruitingVA Office of Research and Development5852026-11-012026-09-17
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
Impella 5.5 SmartAssist - Heart Failure, Cardiogenic Shock
Not applicableRecruitingAbiomed Inc.2502026-10-022026-10-13
RELIEVE-HFrEF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure With Reduced EF
Implantation of the V-Wave Interatrial shunt, Sham (no implant) - Heart Failure and Reduced Ejection Fraction, Heart Failure Chronic
Not applicableNot yet recruitingV-Wave Ltd2502026-09-302026-07-10
Short-Term Outcomes of HFrEF Patients on Guideline-Directed Medical Therapy
Heart Failure, Heart Failure, Systolic
Not yet recruitingAssiut University2502026-09-102026-09-17
Wearable Device-Assisted Remote Management to Improve Prognosis in Patients With Acute Heart Failure Complicated by Atrial Fibrillation: WARM-HF Trial (Stage 2)
wearable device based remote management (GDMT titration for HF, rhythm control and anticoagulation management for AF) - Atrial Fibrillation (AF), Heart Failure and Reduced Ejection Fraction
Not applicableNot yet recruitingBeijing Anzhen Hospital8182026-09-012026-07-09
A Study of LY3971297 in Participants With Heart Failure
LY3971297, Placebo - Heart Failure, Heart Failure, Diastolic
Phase 1RecruitingEli Lilly and Company902026-08-112026-09-22
Heart Failure and Postoperative Outcome in Surgery - a National Registry Study
Heart Failure, Diastolic Heart Failure
Not yet recruitingUmeå University22000002026-08-012026-06-09
Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With Obesity
Tirzepatide, Placebo - Heart Failure and Reduced Ejection Fraction, Obesity & Overweight
Phase 3Not yet recruitingShahid Beheshti University of Medical Sciences602026-07-182026-08-03
HeartMate App-Based Remote Monitoring for Cardiovascular Risk Factor Management
HeartMate App-Based Remote Cardiac Rehabilitation Program, Usual Care with HeartMate App-Based rPPG Measurement Only - Cardiovascular Diseases, Heart Failure, Systolic
Not applicableNot yet recruitingYonsei University2002026-07-142026-07-23
Comparative Effects of Different Inspiratory Muscle Training Modalities in Patients With Heart Failure.
Mechanical Pressure-Threshold IMT Device, PowerBreathe KH2 Electronic IMT Device, Sub-therapeutic Mechanical IMT Device (Sham) - Heart Failure, Heart Failure and Reduced Ejection Fraction
Not applicableEnrolling by invitationUniversidad Nacional Andres Bello602026-06-172026-07-07
Evaluation of Accelerated Bachmann Bundle Area Pacing in Heart Failure With Reduced ejectIon Fraction Who Have electrocarDioGraphic Evidence of Interatrial Block and Indicated for Implantable Cardioverter Defibrillator
BBAP on, BBAP off, RAAP - Heart Failure and Reduced Ejection Fraction
Not applicableNot yet recruitingSeoul National University Hospital1202026-05-012026-04-23
Infusing Needed Iron to Target Insufficiency in Adults Treated for Evidence of Heart Failure
Notification Group, No Notification Group - Iron Deficiency (ID), Heart Failure
Not applicableRecruitingKaiser Permanente4002026-04-202026-10-01
Selenium Intervention Registry Randomized Trial in Heart Failure
Selenium Supplement, Placebo - Heart Failure, Heart Failure and Reduced Ejection Fraction
Phase 3RecruitingSkane University Hospital43262026-04-012026-04-22
Effectiveness and Safety of Uptitration of Guideline Directed MEdical Therapy in Heart Failure With Reduced Ejection Fraction With Limited Kidney Function Assessments
Blinded kidney function assessments - Heart Failure, Heart Failure and Reduced Ejection Fraction
Not applicableNot yet recruitingUniversity Medical Center Groningen3442026-04-012025-12-18
ASCs in Recently Diagnosed Non-ischemic Heart Failure
Allogeneic adipose tissue-derived mesenchymal stem cells, Cryostor CS10 - Non-Ischemic Heart Failure, Reduced Ejection Fraction Heart Failure
Phase 2WithdrawnCell to Cure ApS2026-03-012026-04-01
Pilot Study of StudyU for N-of-1 Trials in HFrEF Patients (N-of-1 App)
beta blockers, StudyU Application - HFrEF - Heart Failure With Reduced Ejection Fraction, Heart Failure
Phase 4Enrolling by invitationWeill Medical College of Cornell University52026-02-102026-02-19
Digoxin After Acute Heart Failure (DIG-DICA)
Usual Care, Digoxin - Acute Heart Failure (AHF)
Phase 4RecruitingHospital General de Agudos "Dr. Cosme Argerich"1202025-12-162026-06-02
Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension
JK07 - HFrEF - Heart Failure With Reduced Ejection Fraction, HFpEF - Heart Failure With Preserved Ejection Fraction
Phase 2WithdrawnSalubris Biotherapeutics Inc2025-12-152026-05-15
Personalized IoT-based Physical Activity Monitoring System for Heart Failure Patients
Device&behavioral - Heart Failure, Reduced Ejection Fraction Heart Failure
Not applicableNot yet recruitingAbant Izzet Baysal University822025-12-132025-09-12
PRIMA-HF: Predicting Myocardial Recovery in Heart Failure Using Cardiac Imaging HAI-HF: High Dosing vs. Standard Dosing Adenosine During Myocardial Perfusion in Heart Failure
HAI-HF: Adenosine Stress [¹⁵O]H₂O PET Imaging, Two different doses of adenosine - Heart Failure and Reduced Ejection Fraction, Heart Failure
Phase 4Enrolling by invitationGødstrup Hospital1802025-12-082025-12-26

Showing 20 of 222. Sign in to see all of them.

Narrower conditions

Heart Failure (115)  ·  Heart Failure, Diastolic (34)  ·  Cardiovascular Diseases (13)  ·  Atrial Fibrillation (12)  ·  Ventricular Dysfunction, Left (12)  ·  Heart Diseases (9)  ·  Myocardial Infarction (8)  ·  Iron Deficiencies (7)  ·  Myocardial Ischemia (7)  ·  Bundle-Branch Block (6)  ·  Coronary Artery Disease (6)  ·  Motor Activity (6)  ·  Arrhythmias, Cardiac (5)  ·  Depression (5)

Broader conditions

Heart Diseases (213)  ·  Cardiovascular Diseases (209)  ·  Heart Failure (107)  ·  Pathological Conditions, Signs and Symptoms (59)  ·  Pathologic Processes (48)  ·  Vascular Diseases (22)  ·  Arrhythmias, Cardiac (21)  ·  Nutritional and Metabolic Diseases (17)  ·  Behavior (15)  ·  Metabolic Diseases (14)  ·  Signs and Symptoms (12)  ·  Ventricular Dysfunction (12)  ·  Cardiac Conduction System Disease (11)  ·  Myocardial Ischemia (11)  ·  Infarction (9)

Interventions

sacubitril and valsartan sodium hydrate drug combination (10)  ·  Valsartan (6)  ·  ferric carboxymaltose (5)  ·  Cardiac Resynchronization Therapy (4)  ·  Enalapril (4)  ·  dapagliflozin (4)  ·  Blood Specimen Collection (3)  ·  Echocardiography (3)  ·  Sodium Chloride (3)  ·  sacubitril (3)  ·  Angiotensin Receptor Antagonists (2)  ·  Bisoprolol (2)  ·  Digoxin (2)  ·  Exercise (2)  ·  Interleukin 1 Receptor Antagonist Protein (2)

Sponsors

Novartis Pharmaceuticals (6)  ·  University of Leeds (5)  ·  Virginia Commonwealth University (5)  ·  University of Colorado, Denver (4)  ·  Aarhus University Hospital (3)  ·  Herlev and Gentofte Hospital (3)  ·  Oslo University Hospital (3)  ·  Abbott Medical Devices (2)  ·  AstraZeneca (2)  ·  BioCardia, Inc. (2)  ·  Bispebjerg Hospital (2)  ·  Boston Scientific Corporation (2)  ·  Chang Gung Memorial Hospital (2)  ·  German Heart Institute (2)  ·  Henrik Wiggers (2)

Countries

United States (82)  ·  United Kingdom (15)  ·  Denmark (14)  ·  Germany (11)  ·  Canada (9)  ·  Brazil (8)  ·  Italy (8)  ·  Sweden (8)  ·  China (7)  ·  Poland (7)  ·  South Korea (7)  ·  Netherlands (6)  ·  France (5)  ·  Norway (5)  ·  Taiwan (5)

Top investigators

Alan J Bank, MD (2)  ·  Amit Noheria, MBBS, SM (2)  ·  Carl Pepine, MD (2)  ·  Daniel D Matlock, MD, MPH (2)  ·  Kenneth C Bilchick, MD (2)  ·  Kevin D O'Brien, MD (2)  ·  Klaus Witte, MD (2)  ·  Michael Zile, MD (2)  ·  Rasmus Borgquist, MD PhD (2)  ·  Abbas A Qayyum, MD MSc PhD (1)  ·  Adam DeVore, MD, MHS (1)  ·  Ahran D Arnold, MBBS, BSc, MSc, MRCP, PhD (1)  ·  Ajit Singh, PHARM D, PhD (1)

Results publications

PMID 11911755, PMID 19293069, PMID 19920054, PMID 19933409, PMID 19958862, PMID 19959119, PMID 20117435, PMID 20362723, PMID 20634483, PMID 20660805, PMID 21111983, PMID 21262990, PMID 21401993, PMID 21464053, PMID 21869636, PMID 22067287, PMID 22154198, PMID 22398347, PMID 22973678, PMID 23099357, PMID 23108436, PMID 23130114, PMID 23249290, PMID 23380000, PMID 23541331, PMID 23592833, PMID 23799908, PMID 24138615, PMID 25221334, PMID 25500165, PMID 25639592, PMID 25700617, PMID 25908674, PMID 25982108, PMID 26011593, PMID 26028263, PMID 26374852, PMID 26692555, PMID 27633393, PMID 27836022, PMID 27956398, PMID 28484920, PMID 28673328, PMID 28694343, PMID 28820057, PMID 28940248, PMID 29331959, PMID 29603546, PMID 29705650, PMID 29747838

NIH funding

1UM1TR004538-01 (1), 2015 (1), 2016 (1), 2018 (1), 2025 (1), R01HL136403 (1), R01HL144937 (1), R01HL168752 (1), R01HL173578 (1), R03AG064371 (1), R21AG075639 (1), R21HL126209 (1)